GF
IOVA icon

Gerstein Fisher’s Iovance Biotherapeutics IOVA Stock Holding History

Gerstein Fisher’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$254K Buy
+30,836
New +$261K 0.03% 358

Other funds holding IOVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gerstein Fisher's IOVA Position: Q3 2016 in Review

Gerstein Fisher opened a new position in Iovance Biotherapeutics (IOVA) in Q3 2016: 30,836 shares worth $254K. The stake represents 0.03% of the portfolio and ranks #358 among its holdings.

93 funds tracked by Wall St. Rank hold IOVA as of Q3 2016.

  • Gerstein Fisher held 30,836 shares of Iovance Biotherapeutics worth $254K as of Q3 2016.
  • Iovance Biotherapeutics was a new Gerstein Fisher position in Q3 2016.
  • Iovance Biotherapeutics made up 0.03% of Gerstein Fisher's portfolio in Q3 2016, its #358 holding.
  • 93 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2016.

Based on Gerstein Fisher's 13F filing for Q3 2016, filed 15 Nov 2016.